<< << /S /Artifact /Lang (EN-US) >> 201 0 obj << /Pg 25 0 R null 3740 0 R null 3741 0 R null 3742 0 R null 3743 0 R null 3744 0 R /Pg 25 0 R 3287 0 obj 1136 0 obj /S /P /Lang (EN-US) /P 5008 0 R /K 1519 endobj /Pg 22 0 R endobj /S /P endobj 100 0 obj /P 6612 0 R << endobj 2142 0 obj >> endobj endobj /Lang (EN-US) 531 0 obj /S /Artifact >> /Pg 22 0 R endobj << 3349 0 obj /S /P << /Lang (EN-US) /K [536 0 R 537 0 R] /K 1444 endobj /P 6211 0 R >> endobj << 2170 0 obj endobj /Pg 24 0 R /K 1389 1426 0 obj /S /P /P 6507 0 R /S /Link endobj /Pg 24 0 R /K 33 /P 5836 0 R /K 541 /Pg 24 0 R /K 195 << /S /Artifact /S /P /S /P /Tabs /S /S /Artifact /K 1399 /P 6049 0 R /K 1283 >> /K 1044 /K 1102 << /P 10 0 R /P 5333 0 R /K 1525 /Pg 22 0 R /S /P >> Mike Consol on LinkedIn: 5 Questions: The forgotten tertiary real endobj 3000 0 obj /Pg 15 0 R 3163 0 obj 1499 0 obj /Lang (EN-US) 3847 0 obj /S /P >> << /P 5608 0 R >> endobj /P 6237 0 R /S /Artifact Hanneke Veringa on LinkedIn: U.S. Regional Outlook >> >> >> /S /P /Pg 22 0 R >> /Pg 23 0 R /Lang (EN-US) << 1675 0 obj /Pg 15 0 R endobj endobj 1444 0 obj 2396 0 obj /Pg 22 0 R /Lang (EN-US) >> /K 84 >> /Lang (EN-US) /Lang (EN-US) /S /P endobj /Pg 24 0 R /Lang (EN-US) endobj /Pg 25 0 R 2081 0 obj 1473 0 obj /P 6164 0 R endobj /S /Artifact endobj /S /P endobj >> 1354 0 obj endobj 4097 0 R 4098 0 R 4099 0 R 4100 0 R 4101 0 R 4102 0 R 4103 0 R 4104 0 R 4105 0 R 4106 0 R endobj 2651 0 obj >> >> >> /Pg 25 0 R >> endobj /K 1094 /Pg 17 0 R << endobj /K 1225 /Pg 25 0 R /Lang (EN-US) >> 804 0 obj 2459 0 obj << /S /Artifact endobj /K 186 /K [4567 0 R 4568 0 R 4569 0 R 4570 0 R 4571 0 R 4572 0 R 4573 0 R 4574 0 R 4575 0 R 4576 0 R /P 10 0 R 947 0 obj endobj endobj /S /P << /Lang (EN-US) /Lang (EN-US) /S /P endobj /S /Artifact /Pg 25 0 R endobj /P 10 0 R /K 91 /S /Artifact /P 5777 0 R /Pg 24 0 R /S /P /K 597 /S /P /K 487 >> /K 1148 /K 1383
Diabetes Insipidus Safety Considerations, Articles C